The University of Illinois was awarded a $1,499,728 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2023, will fund research to investigate a novel approach to reverse volumetric muscle loss following transfemoral amputations, with the goal of improving mobility and function. The research aims to transform health care for service members and the American public through innovative biomedical...
This Project Grant from the Defense Health Agency provides $349,939 to the University of Colorado Denver under the Military Medical Research and Development federal grant program (CFDA 12.420) from February 1, 2023 to January 31, 2026. The grant funds research on transfemoral osseointegrated prosthesis limb-load symmetry training. As the program description notes, the Military Medical Research and Development program supports basic, applied, and advanced biomedical research to improve military...
The University of Washington was awarded a $2,768,756 project grant from the Department of the Army Medical Command through its Military Medical Research and Development program (CFDA 12.420) to evaluate the Northwestern University subischial socket for persons with transfemoral amputation and lower mobility levels. The University will conduct this evaluation from September 1, 2022 through August 31, 2025 in Seattle, Washington. As part of the project, the University will subaward portions of...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
This federal Project Grant award of $293,978.00 was issued by the Defense Health Agency on November 1, 2024 to the University of Illinois under the Military Medical Research and Development (CFDA 12.420) program. The grant is designed to support advanced biomedical research focused on cognition, vascular function, and physical activity in multiple sclerosis. The research, to be conducted over a 2-year period ending on October 31, 2026, aims to transform healthcare for military service members...
The University of Texas at Austin was awarded a $1,499,767 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to investigate the impact of personalized robotic leg prostheses for individuals with transfemoral amputations of varying mobility levels. The research will be conducted from September 2022 through September 2026. A subaward of $150,000 was provided to the Georgia Tech Research Corporation to support...
This $1,971,886 project grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research exploring the impact of microprocessor-controlled knees on prosthesis awareness and overall health. Virginia Commonwealth University is the primary awardee and will work with sub-awardees Hanger, Inc. and the University of Washington on this research from July 2021 through June 2025. The grant aims to transform military and...
The University of Texas Health Science Center at Houston was awarded a $1,498,514 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The grant will fund research from September 2022 through September 2026 to improve functional performance in transfemoral amputees through somatosensory augmentation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
This $399,992 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund research conducted by the University of Nevada, Las Vegas (UNLV) to develop a rehabilitation regimen to improve locomotor function and confidence in lower limb prosthesis users. The three-year project aims to study the effects of training on uneven surfaces to enhance the rehabilitation process and boost the mobility and self-assurance of...
The University of Utah was awarded a $1,498,742 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the development of a motorized hip orthosis for individuals with transfemoral amputations over a four-year period ending September 2026. The orthosis aims to improve mobility and independence for those with upper leg amputations through powered assistance technology. As part of its broader...